Regulation of δ-opioid receptor mRNA levels by receptor-mediated and direct activation of the adenylyl cyclase-protein kinase A pathway

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 610-615

  Buzas, Beata ^a   Rosenberger, John ^a   Cox, Brian M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Competitive PCR; Gene expression; NG108 15 cells; Opioid receptors; Protein kinase A

Indexed keywords

ADENYLATE CYCLASE; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOHEXIMIDE; DACTINOMYCIN; DELTA OPIATE RECEPTOR; FORSKOLIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MESSENGER RNA; PROSTAGLANDIN E1; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GLIOMA CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0031021367     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020610.x     Document Type: Article

References (31)

1. Augustin L. B., Felsheim R. F., Min B. H., Fuchs S. M., Fuchs J. A., and Loh H. H. (1995) Genomic structure of the mouse delta opioid receptor gene. Biochem. Biophys. Res. Commun. 209, 639-647.
2. Bergsbaken C. L., Sommers S. L., and Law P. Y. (1993) Effect of forskolin and isobutylmethylxanthine on delta opioid receptor activity in neuroblastoma X glioma NG108-15 cells. J. Pharmacol. Exp. Ther. 264, 1474-1483.
3. 2-adrenergic receptor. J. Biol. Chem. 264, 16786-16792.
4. Brown B. L., Albano J. D. M., Ekins R. P., Sgherzi A. M., and Tampion W. (1971) A simple and sensitive saturation assay method for measurement of adenosine 3′,5′-cyclic monophosphate. Biochem J. 121, 561-562.
5. Buzas B. and Cox B. M. (1997) Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 76, 479-490.
6. Chen D. and Rothenberg E. V. (1994) Interleukin-2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179, 931-942.
7. + channel. J. Biol. Chem. 269, 7839-7842.
8. Chen Y., Mestek A., Liu J., Hurley J. A., and Yu L. (1993) Molecular cloning and functional expression of a mu opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
9. Chijwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoune T., Naito K., Toshioka T., and Hidaka H. (1990) Inhibition of forskolin induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP dependent protein kinase. N-[2-(bromocinnamylamino)ethyl]-5-isoquinoline-sulphonamide (H-89), of PC12D pheochromocytoma. J. Biol. Chem. 265, 5267-5272.
10. Chrivia J. C., Kwok R. P., Lamb N., Hagiwara M., Montminy M. R., and Goodman R. H. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
11. Collier H. O. J. and Roy A. C. (1974) Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation in rat brain membranes. Nature 248, 24-27.
12. Cowell I. G. (1994) Repression versus activation in the control of gene expression. Trends Biochem. Sci. 19, 38-42.
13. Evans C. H., Keith D. E., Morrison H., Magendzo K., and Edwards R. H. (1992) Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
14. Foulkes N. S., Borelli E., and Sassone-Corsi P. (1991) CREM gene: use of alternative DNA binding domains generate multiple antagonists of cAMP-induced transcription. Cell 64, 739-749.
15. Frey E. and Kebabian J. (1984) A μ opiate receptor in 7315c tumor tissue mediates inhibition of immunoreactive prolactin release and adenylate cyclase. Endocrinology 115, 1797-1804.
16. Hayward M. D., Duman R. S., and Nestler E. J. (1990) Induction of the c-fos protooncogene during opiate withdrawal in the locus coeruleus and other regions of the rat brain. Brain Res. 525, 256-266.
17. Hescheler J., Rosenthal W., Trautwein W., and Schulz G. (1987) The GTP-binding protein Go regulates neuronal calcium channels. Nature 325, 445-446.
18. 1-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells. J. Neurochem. 63, 1635-1645.
19. 2radrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibitor. Mol. Pharmacol. 48, 206-211.
20. Kieffer B. L. Befort K., Gaveriaux-Ruff C., and Hirth C. G. (1992) The δ opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
21. Lemaigre F. P., Ace C. I., and Green M. R. (1993) The cAMP response element binding protein, CREB, is a potent inhibitor of diverse transcriptional activators. Nucleic Acids Res. 21, 2901-2911.
22. Mestek A., Hurley J. H., Bye L. S., Campbell A. D., Chen Y., Tian M., Liu J., Schulman H., and Yu L. (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin dependent kinase and protein kinase C. J. Neurosci. 15, 2396-2406.
23. Molina C. A., Foulkes N. S., Lalli E., and Sassone-Corsi P. (1993) Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75, 875-886.
24. Nestler E. J. (1996) Under siege: the brain on opiates. Neuron 16, 897-900.
25. Parker-Bothelo L. H., Rothermel J. D., Coombs R. V., and Jastroff V. (1988) cAMP analog antagonists of cAMP action. Methods Enzymol. 159, 159-173.
26. Pei G., Kieffer B. L., Lefkowitz R. J., and Freedman N. J. (1995) Agonist-dependent phosphorylation of the mouse d opioid receptor: involvement of G-protein coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173-177.
27. Peterson G. L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356.
28. Sharma S. K., Klee W. A., and Nirenberg M. (1975a) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance Proc. Natl. Acad. Sci. USA 72, 3092-3096.
29. Sharma S. K., Klee W. A., and Nirenberg M. (1975b) Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 74, 3365-3369.
30. Thivierge M., Alami N., Muller E., de Blum-Fernannes A. J., and Rola-Pleszczynski M. (1993) Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP. J. Biol. Chem. 268, 17457-17462.
31. Yamamoto K. K., Gonzales G. A., Biggs W. H., and Montminy M. R. (1988) Phosphorylation induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334, 494-498.